Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity - PubMed (original) (raw)
Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity
Y Lachance et al. DNA Cell Biol. 1991 Dec.
Abstract
While classical 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase deficiency (3 beta-HSD) is a known cause of adrenal hyperplasia resulting in ambiguous genitalia and adrenal insufficiency at birth, nonclassical or late-onset 3 beta-HSD deficiency is found in an important proportion of women with androgen excess. We have previously isolated and sequenced the cDNA and gene for the human type I 3 beta-HSD, which represents the main species expressed in the placenta and skin. Recently, we isolated, sequenced, and expressed the functional cDNA encoding type II 3 beta-HSD, which is the predominant 3 beta-HSD expressed in human adrenals and gonads. The present study describes the isolation and complete sequence of the corresponding type II 3 beta-HSD gene, which is the form most likely responsible for human 3 beta-HSD deficiency. The structural gene contains four exons of 57, 231, 165, and 1,214 bp, respectively, separated by introns of 128, 3,383, and 2,162 bp. DNA sequence analysis of the 5'-flanking region reveals the existence of two putative TATA boxes situated 28 and 140 nucleotides upstream from the transcription start site whereas two putative CAAT boxes are located 57 and 38 nucleotides upstream from the TATA boxes, respectively. A restriction fragment length pattern specific for each gene has been characterized. The present findings should provide the tools required for detailed analysis of the molecular basis of 3 beta-HSD deficiency as well as of normal sex steroid biosynthesis.
Similar articles
- Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.
Lachance Y, Luu-The V, Labrie C, Simard J, Dumont M, de Launoit Y, Guérin S, Leblanc G, Labrie F. Lachance Y, et al. J Biol Chem. 1990 Nov 25;265(33):20469-75. J Biol Chem. 1990. PMID: 2243100 - Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.
Rhéaume E, Lachance Y, Zhao HF, Breton N, Dumont M, de Launoit Y, Trudel C, Luu-The V, Simard J, Labrie F. Rhéaume E, et al. Mol Endocrinol. 1991 Aug;5(8):1147-57. doi: 10.1210/mend-5-8-1147. Mol Endocrinol. 1991. PMID: 1944309 - Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
Sanchez R, Rhéaume E, Laflamme N, Rosenfield RL, Labrie F, Simard J. Sanchez R, et al. J Clin Endocrinol Metab. 1994 Mar;78(3):561-7. doi: 10.1210/jcem.78.3.8126127. J Clin Endocrinol Metab. 1994. PMID: 8126127 - Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
Simard J, Moisan AM, Morel Y. Simard J, et al. Semin Reprod Med. 2002 Aug;20(3):255-76. doi: 10.1055/s-2002-35373. Semin Reprod Med. 2002. PMID: 12428206 Review. - Ontogeny and subcellular localization of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) in the human and rat adrenal, ovary and testis.
Pelletier G, Dupont E, Simard J, Luu-The V, Bélanger A, Labrie F. Pelletier G, et al. J Steroid Biochem Mol Biol. 1992 Oct;43(5):451-67. doi: 10.1016/0960-0760(92)90084-v. J Steroid Biochem Mol Biol. 1992. PMID: 1390295 Review.
Cited by
- Ellagic Acid Triggers the Necrosis of Differentiated Human Enterocytes Exposed to 3-Nitro-Tyrosine: An MS-Based Proteomic Study.
Díaz-Velasco S, Delgado J, Peña FJ, Estévez M. Díaz-Velasco S, et al. Antioxidants (Basel). 2022 Dec 17;11(12):2485. doi: 10.3390/antiox11122485. Antioxidants (Basel). 2022. PMID: 36552693 Free PMC article. - Genetic Testing for a Patient with Suspected 3 Beta-Hydroxysteroid Dehydrogenase Deficiency: A Case of Unreported Genetic Variants.
Menegatti E, Tessaris D, Barinotti A, Matarazzo P, Einaudi S. Menegatti E, et al. J Clin Med. 2022 Sep 29;11(19):5767. doi: 10.3390/jcm11195767. J Clin Med. 2022. PMID: 36233635 Free PMC article. - History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology.
Miller WL, White PC. Miller WL, et al. Endocr Rev. 2023 Jan 12;44(1):70-116. doi: 10.1210/endrev/bnac019. Endocr Rev. 2023. PMID: 35947694 Free PMC article. - 11-Oxygenated androgens in health and disease.
Turcu AF, Rege J, Auchus RJ, Rainey WE. Turcu AF, et al. Nat Rev Endocrinol. 2020 May;16(5):284-296. doi: 10.1038/s41574-020-0336-x. Epub 2020 Mar 16. Nat Rev Endocrinol. 2020. PMID: 32203405 Free PMC article. Review. - Intracrinology-revisited and prostate cancer.
Penning TM, Detlefsen AJ. Penning TM, et al. J Steroid Biochem Mol Biol. 2020 Feb;196:105499. doi: 10.1016/j.jsbmb.2019.105499. Epub 2019 Oct 12. J Steroid Biochem Mol Biol. 2020. PMID: 31614208 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases